Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Tofacitinib may help regrow hair in alopecia areata patients.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Doxazosin and finasteride negatively affect sexual function in men with BPH.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

Patients with melanoma who saw dermatologists and were from higher-income areas were more likely to have follow-up visits, which was linked to lower mortality.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

The convention discussed various skin conditions, treatments, and the importance of continuous learning in dermatology nursing.

Cilostazol may help hair grow and could be a new treatment for hair loss.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

All-trans-retinoic acid stops mink hair growth by affecting cell growth and causing cell death.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Activating STAT5 in the skin's dermal papilla is key for starting hair growth, regenerating hair follicles, and healing wounds.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

No cure exists for alopecia areata, and treatments are personalized.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

A child with a rare scalp condition regrew hair after treatment.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.